(Q44911093)

7 December 2017

Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas (English)

1 reference

7 December 2017

Martin R Graf

1

1 reference

PubMed ID

15933813

7 December 2017

Jeremy T Sauer

series ordinal

2

1 reference

PubMed ID

15933813

7 December 2017

Randall E Merchant

series ordinal

3

1 reference

7 December 2017

1 May 2005

1 reference

Journal of Neuro-Oncology

7 December 2017

1 reference

7 December 2017

73

1 reference

7 December 2017

29-36

1 reference

7 December 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-004-3347-x

7 December 2017

0 references

cites work

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-004-3347-X

Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-004-3347-X

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-004-3347-X

Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction

21 January 2018

1 reference

12 December 2020

Tumor-specific transplantation immunity to intracerebral challenge with cells from a methylnitrosourea- induced brain tumor

1 reference

12 December 2020

Glioma immunology and immunotherapy.

1 reference

12 December 2020

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

1 reference

12 December 2020

Cytokine-secreting tumor cell vaccines

1 reference

12 December 2020

Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination

1 reference

12 December 2020

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

1 reference

12 December 2020

Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery

1 reference

12 December 2020

The induction of tumors of the nervous system with intravenous methylnitrosourea.

1 reference

12 December 2020

Cancer vaccines: an update

1 reference

12 December 2020

Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.

1 reference

12 December 2020

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

1 reference

12 December 2020

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

12 December 2020

Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats

1 reference

12 December 2020

7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model

1 reference

12 December 2020

Progress in active-specific immunotherapy of brain malignancies

1 reference

12 December 2020

Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats

1 reference

12 December 2020

Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors.

1 reference

12 December 2020

Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique

1 reference

12 December 2020

Dendritic cell based tumor vaccines

1 reference

12 December 2020

Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy

1 reference

12 December 2020

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

1 reference

12 December 2020

Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells

1 reference

12 December 2020

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

1 reference

12 December 2020

Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity

1 reference

12 December 2020

Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

1 reference

12 December 2020

Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma

1 reference

12 December 2020

Brain tumor survival: results from the National Cancer Data Base

1 reference

12 December 2020

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

1 reference

12 December 2020

Antitumor vaccination using peptide based vaccines.

1 reference

12 December 2020

Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas

1 reference

12 December 2020

Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors

1 reference

12 December 2020

Differential retention of rhodamine 123 by avian sarcoma virus-induced glioma and normal brain tissue of the rat in vivo

1 reference

12 December 2020

Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture

1 reference

12 December 2020

10.1007/S11060-004-3347-X

Identifiers

DOI

1 reference

7 December 2017

1 reference